The aim of the EU funded project RESTORE is to treat osteoarthritis (OA) by generating functional cartilage through 3D bioprinting technology. A Swedish research team within RESTORE has now achieved a major scientific milestone in the treatment of OA; they have been able to generate functional cartilage tissue by 3D bioprinting chondrocytes into OA lesions. The study was recently published in the scientific journal CARTILAGE (Gatenholm, Lindahl, Brittberg, & Simonsson, 2020) and featured in a special report by Innovation News Network.